syngene

Syngene International Limited, commonly known as Syngene, is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) in the biopharmaceutical sector. Based in Bengaluru, India, it operates as a subsidiary of Biocon Limited and serves global pharmaceutical and biotechnology customers. Syngene provides integrated research and development services across the drug development lifecycle, including discovery chemistry and biology, high-throughput screening, pharmacology and toxicology, preclinical development, clinical development support, analytical services, process development, formulation development, and manufacturing at kilo- to pilot-scale under GMP-compliant conditions. The company collaborates with multinational pharmaceutical firms as well as biotech startups, delivering end-to-end support from early discovery to manufacturing.

Facilities and capabilities are concentrated in India, with significant operations at Biocon Park in Bengaluru and additional sites designed to support rapid project execution and regulatory compliance. Syngene emphasizes scientific expertise, data analytics, and scalable operations to accelerate timelines for its clients. As a publicly traded company on Indian stock exchanges, it maintains governance structures typical of listed corporate entities, with Biocon holding a substantial stake.

Notable aspects include a broad portfolio across therapeutic areas, a robust development and manufacturing infrastructure, and a strategy focused on integrated services that combine biology, chemistry, and manufacturing to shorten development timelines.